0000818479false00008184792021-05-262021-05-26

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

May 27, 2021 (May 26, 2021)

Date of Report (Date of earliest event reported)

DENTSPLY SIRONA Inc.

(Exact name of registrant as specified in its charter)

Delaware

0-16211

39-1434669

(State or other jurisdiction of incorporation or organization)

(Commission File Number)

(I.R.S. Employer Identification No.)

13320 Ballantyne Corporate Place,

Charlotte

North Carolina

28277-3607

(Address of Principal Executive Offices)

(Zip Code)

(844) 848-0137

(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, par value $0.01 per share			XRAY			The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

o

---

Item 5.07 Submission of Matters to a Vote of Security Holders.

The annual meeting of shareholders of DENTSPLY SIRONA Inc. was held on May 26, 2021. The following matters were voted upon at the Annual Meeting, with the results indicated:

1.Election of ten directors to serve a one-year term and until his or her successor is duly elected and qualified.

			Director			For			Against			Abstain			Broke Non-Votes
1a.			Eric K. Brandt			178,802,673			13,497,284			1,447,469			6,718,632
1b.			Donald M. Casey Jr.			193,291,649			315,908			139,869			6,718,632
1c.			Willie A. Deese			189,040,040			4,635,518			71,868			6,718,632
1d.			Betsy D. Holden			184,072,146			9,605,836			69,444			6,718,632
1e.			Clyde R. Hosein			193,349,281			243,736			154,409			6,718,632
1f.			Arthur D. Kowaloff			191,221,796			2,442,492			83,138			6,718,632
1g.			Harry M. Jansen Kraemer Jr.			191,979,616			1,240,009			527,801			6,718,632
1h.			Gregory T. Lucier			190,374,101			2,925,483			447,842			6,718,632
1i.			Leslie F. Varon			190,184,675			3,512,095			50,656			6,718,632
1j.			Janet S. Vergis			192,518,579			1,160,339			68,508			6,718,632

2.Ratification of Appointment of PricewaterhouseCoopers LLP as DENTSPLY SIRONA Inc.'s independent registered public accounting firm for 2021.

For			Against			Abstain			Broker Non-Votes
188,757,435			11,661,816			46,807			0

3.Non-binding advisory vote on the Company's executive compensation.

For			Against			Abstain			Broker Non-Votes
178,929,596			14,230,773			587,057			6,718,632

---

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

            DENTSPLY SIRONA Inc.

By:			/s/ Keith J. Ebling
			Keith J. Ebling
			Executive Vice President, General Counsel and Secretary

Date: May 27, 2021